Tirzepatide (trade name Zepbound) promoted greater weight loss in individuals with obesity than semaglutide (trade name Wegovy) in a clinical trial that compared the safety and efficacy of the injectable drugs.
Weill Cornell Medicine and colleagues in Tanzania are fostering a new generation of M.D./Ph.D. researchers, with implications for improved health care outcomes worldwide.
The modification commonly found on messenger RNAs plays a surprisingly large role in how cells respond to stress, according to a study led by Weill Cornell Medicine investigators.
A new study by researchers at Cornell Tech and the University of Pennsylvania shows freelance writers who are suspected of using AI have worse evaluations and hiring outcomes.
A team of researchers from Cornell Tech is reimagining how technology can support users with speech disabilities – not just in functional speech, but also in making real-time jokes during conversations.
Cornell Tech leadership, alongside elected officials, faculty, students, staff, and the Roosevelt Island community, hosted an official ribbon-cutting ceremony to celebrate the opening of the campus’s new MakerLAB on May 2.
Cornell researchers found that by prioritizing the perspectives of white Americans instead of those from underrepresented groups, studies of pandemic disparities likely missed important insights from those most affected by COVID-19.
A ceremonial ribbon-cutting on May 1 formally welcomed the Feil Family and Weill Family Residence Hall, located at the northwest corner of 74th Street and York Avenue, into Weill Cornell Medicine’s main campus.
